Vaccines
17 April 2017
ACARIZAX® approved in Europe for use in adolescent patients with house dust mite-induced allergic rhinitis11 April 2017
Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial11 April 2017
Zika virus: Themis Bioscience initiates worldwide first study with live attenuated recombinant vaccine28 March 2017
CureLab Oncology, Inc. Publishes Results of Phase I/IIa Clinical Trials of Its Anti-Cancer DNA Vaccine, Elenagen24 March 2017
Pfizer Receives Positive CHMP Opinion for TRUMENBA® for Prevention of Meningococcal Group B Disease20 March 2017
GeoVax Reports Promising Results for Zika Vaccine13 March 2017
Bavarian Nordic Announces Collaboration to Evaluate CV301 and Tecentriq in Bladder Cancer9 March 2017
CyTuVax starts its Phase 2 BE RESPONDER! study28 February 2017
Astellas and Affinivax Announce Worldwide Partnership for MAPS Vaccine targeting Pneumococcal Disease28 February 2017
Inovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy23 February 2017
Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious DiseasesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports